The study presented here demonstrates the use of a human liver MPS to determine the regulation by the cell non-autonomous tumor microenvironment of ER+ breast cancer metastatic phenotypes conferred by specific ESR1 mutations. This evidence concerns the gene ESR1 and breast cancer.